Later competence and adaptation in infants who survive severe heart defects

Child Development
|October 1, 1983
PubMed

Insights

Children with transposition of the great arteries (TGA) who undergo heart surgery face developmental risks. Multiple medical and psychosocial risk factors significantly compromise their neurodevelopmental outcomes.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Congenital Heart Disease Research

Background:

  • Transposition of the great arteries (TGA) is a complex congenital heart defect requiring surgical intervention.
  • Infancy open-heart surgery with cardiopulmonary bypass can impact neurodevelopmental outcomes in TGA patients.
  • Identifying risk factors is crucial for predicting and mitigating adverse developmental trajectories.

Purpose of the Study:

  • To develop a model assessing risk potential for developmental outcomes in TGA children post-surgery.
  • To evaluate the impact of cardiac, medical, surgical, and family-stress factors on neurodevelopment.
  • To correlate cumulative risk scores with neurologic and psychologic measures.

Main Methods:

  • Retrospective analysis of 31 TGA children undergoing infant open-heart surgery.
  • Assessment using neurologic measures: anatomic abnormalities, functional impairment, EEG, PVEP.
  • Evaluation with psychologic measures: IQ, achievement, perceptual-motor function, behavior.
  • Development of a cumulative risk score incorporating various medical and psychosocial variables.

Main Results:

  • Adverse developmental outcomes linked to medical factors: hypoxia, growth failure, heart failure, stroke, CNS infection.
  • Psychosocial factors like socioeconomic status and life stress moderated outcomes.
  • Abnormal EEGs, PVEPs, and neurologic exams correlated with higher cumulative risk scores.
  • Cumulative risk score showed significant correlations with neurologic outcome, IQ, achievement, and perceptual-motor function.

Conclusions:

  • A cumulative risk model effectively predicts neurodevelopmental outcomes in TGA survivors.
  • Single risk events may have manageable impacts, but multiple factors significantly compromise development.
  • Early identification and management of risk factors are essential for improving long-term outcomes in TGA patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...